Cite
HARVARD Citation
Olson, R. et al. (n.d.). 2: Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for Up to Five Oligometastases: Preliminary Results of the SABR-5 Trial. Radiotherapy and oncology. pp. S4-. [Online].